Long-awaited progress in addressing genetic discrimination in the United States

A Correction to this article was published on 27 October 2020

This article has been updated

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 23 October 2020

    In original version of the Article the Disclosure statement omitted that Dr. Green receives compensation for advising the following companies: AIA, SavvySherpa, Verily, Wamberg; and is co-founder of Genome Medical, Inc, a technology and services company providing genetics expertise to patients, providers, employers and care systems. This has now been added to both the PDF and HTML versions of the Article.

References

  1. 1.

    Rothstein MA. Time to end the use of genetic test results in life insurance underwriting. J Law Med Ethics. 2018;46:794–801.

    Article  Google Scholar 

  2. 2.

    National Human Genome Research Institute. Genome Statute and Legislation Database. 2020. https://www.genome.gov/about-genomics/policy-issues/Genome-Statute-Legislation-Database.

  3. 3.

    American Medical Association. Genetic discrimination: a report of the American Medical Association Council on Science and Public Health. 2013. Chicago: American Medical Association; 2013.

  4. 4.

    Amendola LM, Robinson JO, Hart R, et al. Why patients decline genomic sequencing studies: experiences from the CSER Consortium. J Genet Couns. 2018;27:1220–1227.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Prince AER. Political economy, stakeholder voices, and saliency: lessons from international policies regulating insurer use of genetic information. J Law Biosci. 2019;5:461–494.

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Joly Y, Feze IN, Song L, Knoppers BM. Comparative approaches to genetic discrimination: chasing shadows? Trends Genet. 2017;33:299–302.

    CAS  Article  Google Scholar 

  7. 7.

    American Council of Life Insurers. Summary of 2020 legislative trends specific to risk classification topics. 2020. https://www.acli.com/-/media/ACLI/Files/Events/MED2020/RiskClassificationIssuesOverviewUpdateFebruary2020.ashx?la=en.

  8. 8.

    Canadian Institute of Actuaries. Statement on genetic testing and insurance, Canadian Institute of Actuaries, Ottawa. 2014. https://www.cia-ica.ca/docs/default-source/2014/214073e.pdf.

  9. 9.

    Macdonald A, Yu F. The impact of genetic information on the insurance industry: conclusions from the ‘bottom-up’ modelling programme. ASTIN Bull. 2011;41:343–376.

    Google Scholar 

  10. 10.

    Barlow-Stewart K, Liepins M, Doble A, Otlowski M. How are genetic test results being used by Australian life insurers? Eur J Hum Genet. 2018;26:1248–1256.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was funded by the National Human Genome Research Institute of the National Institutes of Health under award number R00HG008819 (A.E.R.P.).

Author information

Affiliations

Authors

Corresponding author

Correspondence to A. E. R. Prince MPP.

Ethics declarations

Disclosure

A.C.F.L. has <$10,000 stock in Fabric Genomics. R.C.G. receives compensation for advising the following companies: AIA, Applied Therapeutics, Grail, Humanity, SavvySherpa, Wamberg Advisors; and is cofounder of Genome Medical, Inc, a technology and services company providing genetics expertise to patients, providers, employers, and care systems. A.E.R.P. declares no conflicts of interest. Dr. Green receives compensation for advising the following companies: AIA, SavvySherpa, Verily, Wamberg; and is co-founder of Genome Medical, Inc, a technology and services company providing genetics expertise to patients, providers, employers and care systems.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lewis, A.C.F., Green, R.C. & Prince, A.E.R. Long-awaited progress in addressing genetic discrimination in the United States. Genet Med (2020). https://doi.org/10.1038/s41436-020-01002-y

Download citation

Search